Please login to the form below

Not currently logged in
Email:
Password:

Financials

This page shows the latest Financials news and features for those working in and with pharma, biotech and healthcare.

Valeant shares slide on fears of filing default

Valeant shares slide on fears of filing default

Valeant's financial rollercoaster took another sharp turn yesterday after the company cut its revenue forecasts for 2016 and reported a fourth-quarter loss.

Latest news

More from news
Approximately 75 fully matching, plus 1,010 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    This means ensuring that there are clear financial rewards available to drug developers if they succeed in bringing life-saving new AMR medicines to patients.

  • Beyond caring: learning from the unsung advocates in cancer care

    They can range from a loss of income if patients and their advocates give up work, to how language, education and financial barriers may prevent them from accessing important information and

  • Is trust in healthcare improving? Is trust in healthcare improving?

    However, while the sector sits ahead of industries such as financial services, energy and fashion, it lags well behind the retail, manufacturing and technology sectors.

  • Health on instalment Health on instalment

    Health on instalment. Can US-style financial engineering underwrite ultra-expensive gene therapies? ... This unique brand of financial ingenuity seems poised to enter the healthcare world.

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    The next challenge is how to effectively distribute information to different countries, which brings both translational as well as financial repercussions.

More from intelligence
Approximately 1 fully matching, plus 188 partially matching documents found.

Latest appointments

  • Dermavant strengthens executive team Dermavant strengthens executive team

    Peterson, who previously worked at Sienna Biopharmaceuticals as its chief financial officer, comes to Dermavant Sciences with experience in the dermatology space. ... He has previously served as chief financial officer for Novan and chief financial

  • FTI Consulting appoints Andrew Ward FTI Consulting appoints Andrew Ward

    Ward joins the group from the Financial Times, where he was the pharmaceuticals correspondent for almost three years, covering the business, finance, science and regulation of the global pharmaceuticals and medical

  • Celgene’s CEO Mark Alles is appointed as chairman Celgene’s CEO Mark Alles is appointed as chairman

    Hugin initially joined Celgene as its chief financial officer and then subsequently became chief operating officer and chief executive officer.

  • Sophia Genetics appoints CFO Sophia Genetics appoints CFO

    Data-driven medicine firm Sophia Genetics has appointed its new chief financial officer in the form of Valentin Matillon. ... He brings over two decades worth of experience in senior financial management positions to the group, holding roles in

  • Perrigo appoints Gerresheimer’s Uwe Rohrhoff as CEO Perrigo appoints Gerresheimer’s Uwe Rohrhoff as CEO

    The appointment has been one of a few changes at the company, just last year Perrigo’s chief financial officer Judy Brown stepped down from her role to join Amgen, and

More from appointments
Approximately 0 fully matching, plus 205 partially matching documents found.

Latest from PMHub

  • HL TRAD Limited

    HL TRAD Limited. HL TRAD was founded by two specialists in B2B language services, who wanted to create an innovative company aimed exclusively at the legal and financial sectors.

  • Hayward Medical Communications starts 26th year with new partnership at the helm

    Martin Griffiths and Emily Rutterford continue to manage the publishing programme and financial control, respectively. ... financial year, I’ m confident that we’ re ready to do exactly that!”.

  • How Transparent Is Transparency?

    fruit? The data published gives us oversight of how financial interactions are apportioned, how much money is spent on R&D related activities versus commercial activities. ... The data published gives us oversight of how financial interactions are

  • Top 5 things I learned at last week's PM Society seminar on agency/procurement relationships

    There is a paradox where Agency financial stability is important to all client companies; yet some of those same client companies do not follow  government guidelines on prompt payment, requiring agencies

  • Healthcare in the Digital Age

    HEALTHCARE IN FLUX. The challenge for the pharmaceutical industry is now about steering new therapies through a maelstrom of financial and regulatory uncertainty into the hands of medical professionals.Navigating the ... view” on page 4 – provides a

More from PMHub
Approximately 0 fully matching, plus 103 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics